IACT Health, a Columbus Georgia clinical research site, is somewhat unique in that they are located adjacent to a community hospital, Piedmont Health (Columbus Regional Midtown Campus) with access to the 583-bed hospital and Level II trauma center, Level III NICU, pediatric intensive care, stroke center and multiple urgent care facilities. The hospital recently received a $1 million grant to add 36 new beds to an unused area of the campus for COVID-19 patients. IACT Health is one of the studies nationwide testing a monoclonal antibodies-based therapy. They do not share what the investigational product is nor the sponsor’s name. The site is part of the growing hyperCORE International “super site network.”
Recently, Cindy Centofanti with local ABC media WVTM 9 visited with IACT Health to discuss COVID-19 research in western Georgia. Cassandra Motle, clinical research coordinator for the research site, reported that the participants in this study testing monoclonal antibodies on those that have been tested positive for SARS-CoV-2, the virus behind COVID-19. Ms. Motle emphasized, “It kind of teaches the body to fight the virus by building antibodies to combat it” ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).